4 transcripts
ITCI
Earnings call transcript
NASDAQ
2024 Q2
7 Aug 24
, what you're powering and expectations for placebo response here and how you're controlling for it, especially since the trial has two active arms.
Maybe
ITCI
Earnings call transcript
NASDAQ
2024 Q1
7 May 24
their responses and their enthusiasm for CAPLYTA. Suresh is at APA. I think he's sitting in some room after the side right now. So maybe, Suresh, do you want
ITCI
Earnings call transcript
NASDAQ
2023 Q4
22 Feb 24
for as we think about CAPLYTA's potential differentiation in adjunctive MD such as response rates, remission rates, safety profile, anything else
ITCI
Earnings call transcript
NASDAQ
2023 Q2
3 Aug 23
receive polypharmacy and oftentimes with very poor responses and they are a high burden on the health care system as well as non-responders to these more
- Prev
- 1
- Next